PODD: 인슐릿

PODD News

• 15:24 인슐렛, FDA 승인에 TD Cowen, 목표가 379달러 유지
• 15:23 Insulet stock price target maintained at $379 by TD Cowen on FDA clearance
• 14:45 Here's Why Insulet (PODD) is a Strong Growth Stock
• 13:34 Here's Why You Should Add CONMED Stock to Your Portfolio Now
• 12:10 FDA clears Insulet’s enhanced Omnipod 5 insulin delivery system
• 21:47 Insulet Corporation: Excellent Business, Valuation Hurdle Remains (PODD)
• 21:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.89%
• 17:45 Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice
• 15:12 인슐렛, UBS 목표 주가 400달러 유지…경쟁력 높은 해자
• 15:11 Insulet stock price target maintained at $400 by UBS on competitive moat
• 14:50 Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
• 12:25 인슐렛, 견조한 성장 전망에 캐너코드 제뉴이티 목표가 상향
• 12:23 Canaccord Genuity raises Insulet stock price target to $432 on growth plan
• 10:15 Zacks.com featured highlights include Insulet, Sandisk and O-I Glass
• 22:00 인슐렛 목표가 상향, Canaccord Genuity
• 21:59 Canaccord Genuity raises Insulet stock price target to $432 on growth plan
• 13:42 인슐렛, Bernstein, ’시장수익률 상회’ 등급 재확인, 목표가 410달러
• 13:41 Bernstein reiterates Outperform rating on Insulet stock with $410 target
• 13:37 인슐렛, UBS ’매수’ 등급 유지…성장 전망 긍정적
• 13:35 Insulet stock holds Buy rating at UBS on strong growth outlook
• 12:00 트루이스트 증권, 인슐렛 목표 주가 412달러로 상향